CD206+IL-4Rα+ MACROPHAGES ARE DRIVERS OF ADVERSE CARDIAC REMODELING IN ISCHEMIC CARDIOMYOPATHY
Qiongxin Wang, Mohamed Ameen Ismahil, Yujie Zhu, Gregg Rokosh, Tariq Hamid, Guihua Zhou, Steven M. Pogwizd, View ORCID ProfileSumanth D. Prabhu
doi: https://doi.org/10.1101/2024.10.01.24314741
Qiongxin Wang
1Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL
2Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan, China,
3Division of Cardiology, Department of Medicine, Washington University School of Medicine, St. Louis, MO
PhDMohamed Ameen Ismahil
1Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL
3Division of Cardiology, Department of Medicine, Washington University School of Medicine, St. Louis, MO
PhDYujie Zhu
1Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL
3Division of Cardiology, Department of Medicine, Washington University School of Medicine, St. Louis, MO
MD, PhDGregg Rokosh
1Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL
3Division of Cardiology, Department of Medicine, Washington University School of Medicine, St. Louis, MO
PhDTariq Hamid
1Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL
3Division of Cardiology, Department of Medicine, Washington University School of Medicine, St. Louis, MO
PhDGuihua Zhou
1Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL
MD, PhDSteven M. Pogwizd
1Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL
MDSumanth D. Prabhu
1Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL
3Division of Cardiology, Department of Medicine, Washington University School of Medicine, St. Louis, MO
MDData Availability
All data are available upon reasonable request.
Posted October 03, 2024.
CD206+IL-4Rα+ MACROPHAGES ARE DRIVERS OF ADVERSE CARDIAC REMODELING IN ISCHEMIC CARDIOMYOPATHY
Qiongxin Wang, Mohamed Ameen Ismahil, Yujie Zhu, Gregg Rokosh, Tariq Hamid, Guihua Zhou, Steven M. Pogwizd, Sumanth D. Prabhu
medRxiv 2024.10.01.24314741; doi: https://doi.org/10.1101/2024.10.01.24314741
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)